Performance of FDG-PET/CT (PET/CT) and contrast enhanced MRI (ceMRI) in the evaluation of hepatic metastasis of gastrointestinal (GI) malignancies
Neetha Gandikota(Mount Sinai Medical Center), Lale Kostakoglu(Mount Sinai Hospital), Steven Peti(Icahn School of Medicine at Mount Sinai), Daniel M. Labow(Danbury Hospital), Josef Macháč(Active Medicine (United Kingdom)), Sherif Heiba(Mount Sinai Medical Center), Sasan Roayaie(White Plains Hospital), William Simpson(Mount Sinai Hospital)
Journal of Nuclear Medicine
May 1, 2011
Cited by 0
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k